Sensorcaine(r) (bupivacaine Hci And Epinephrine) Injection, Solution
Product Images NDC 51662-1397

18 FDA label images from Hf Acquisition Co Llc, Dba Healthfirst · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 18 technical images submitted to the FDA as part of the official labeling for Sensorcaine(r) (bupivacaine Hci And Epinephrine) (NDC 51662-1397). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

00351662139721 Sensorcaine Pouch Label

00351662139721 Sensorcaine Pouch Label
Label for SENSORCAINE (Bupivacaine HCl and Epinephrine) injection solution containing 0.25% (125 mg/50 mL) with Epinephrine 1:200,000 as bitartrate in a 50 mL vial. The label includes NDC 51662-1397-2, lot number, expiration date 2025-01-01, usage instructions indicating infiltration and nerve block only, storage conditions, and manufacturer information for HF Acquisition Co LLC, Mukilteo, WA.*
FDA Label Image

00351662139738 Sensorcaine Rfid Label

00351662139738 Sensorcaine Rfid Label
A barcode label for SENSORCAINE (BUPIVACAINE HCI AND EPINEPHRINE) distributed by HF Acquisition Co., LLC, Mukilteo, WA 98275. The label includes several identification numbers and barcodes, along with the instruction to see the manufacturer's package insert. The label also states 'RX ONLY.'*
FDA Label Image

00351662139738 Sensorcaine Case Label

00351662139738 Sensorcaine Case Label
SENSORCAINE(R) with epinephrine 1:200,000 (as bitartrate) 0.25% 125mg/50mL (2.5mg/mL) solution injection in a 50mL vial, packaged 25 per box. Label includes NDC 51662-1397-3, lot number, expiration date, usage instructions for infiltration and nerve block, storage conditions, manufacturing details by HF Acquisition Co LLC, Mukilteo, WA, and a QR code.*
FDA Label Image

Dosage And Administration (Dosage And Administration)

Dosage And Administration (Dosage And Administration)
Table presenting dosage and motor block information for SENSORCAINE(R) (BUPIVACAINE HCI AND EPINEPHRINE) injection solution. It lists types of nerve blocks, concentration percentages, dose ranges in mL and mg, and the extent of motor block for various block types such as local infiltration, epidural, caudal, peripheral nerves, retrobulbar, sympathetic, and dental.*
FDA Label Image

How Supplied 1 (How Supplied 1)

How Supplied 1 (How Supplied 1)
A data table presenting product codes, units of sale, strengths, and package details for various formulations of a drug. Strengths are given as mg per mL and percentages, with package sizes including 10 mL and 30 mL single-dose vials, and trays of 25 or packages of 5. The table includes multiple NDC codes for different strengths and package configurations.*
FDA Label Image

How Supplied 2 (How Supplied 2)

How Supplied 2 (How Supplied 2)
A data table listing multiple product codes, units of sale, strengths, and packaging details for various formulations of a drug product. The table provides NDC numbers, vial sizes, concentration strengths (mg per mL), and pack counts such as trays of 25 or packaged in 5. The data appears to categorize different dosage and packaging options systematically.*
FDA Label Image

How Supplied 3 (How Supplied 3)

How Supplied 3 (How Supplied 3)
A table showing product codes, units of sale, strengths, and package details for a drug. The units of sale are trays of 25 with two strength options: 125 mg per 50 mL (2.5 mg/mL, 0.25%) and 250 mg per 50 mL (5 mg/mL, 0.50%). Each strength is packaged in a 50 mL multiple-dose vial with corresponding NDC numbers.*
FDA Label Image

How Supplied 4 (How Supplied 4)

How Supplied 4 (How Supplied 4)
This data table lists product codes, units of sale, strengths, and packaging information for two formulations of SENSORCAINE (Bupivacaine HCl and Epinephrine) injection solutions. It details 125 mg per 50 mL (2.5 mg/mL, 0.25%) and 250 mg per 50 mL (5 mg/mL, 0.50%) strengths, each supplied in 50 mL multiple-dose vials and trays of 25.*
FDA Label Image

Indications And Usage (Indications And Usage)

Indications And Usage (Indications And Usage)
A data table showing the recommended concentrations of SENSORCAINE (BUPIVACAINE HCl and Epinephrine) injection solution for various anesthesia techniques, including local infiltration at 0.25%, peripheral nerve block at 0.25% and 0.5%, retrobulbar block at 0.75%, sympathetic block at 0.25%, lumbar epidural at 0.25%, 0.5%, and 0.75% (not for obstetrical anesthesia), caudal at 0.25% and 0.5%, and epidural test dose and dental blocks at 0.5% with epinephrine 1:200,000.*
FDA Label Image
FDA Label Image

Precautions (Precautions)

Precautions (Precautions)
A table listing drug classes and examples, including Nitrates/Nitrites (nitric oxide, nitroglycerin, nitroprusside, nitrous oxide), Local anesthetics (articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine), Antineoplastic agents (cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase), Antibiotics (dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides), Antimalarials (chloroquine, primaquine), Anticonvulsants (phenobarbital, phenytoin, sodium valproate), and Other drugs (acetaminophen, metoclopramide, quinine, sulfasalazine).*
FDA Label Image

Serialized Labeling (Serialized Vial)

Serialized Labeling (Serialized Vial)
Vial of Sensorcaine (Bupivacaine HCl and Epinephrine) Injection, USP, 0.25% strength with epinephrine 1:200,000, labeled for infiltration and nerve block use. The label states the vial contains 50 mL of solution, is a multiple dose vial, distributed by HF Acquisition Co., LLC.*
FDA Label Image

Structure 1 (Structure 1)

Structure 1 (Structure 1)
Chemical structure of Bupivacaine hydrochloride monohydrate as shown in the image, depicting the molecular arrangement including a piperidine ring, amide linkage, and methyl-substituted aromatic ring.*
FDA Label Image

Structure 2 (Structure 2)

Structure 2 (Structure 2)
Chemical structure diagram showing the molecular arrangement of epinephrine, an active ingredient in SENSORCAINE (BUPIVACAINE HCI AND EPINEPHRINE) injection solution. The diagram includes a benzene ring with two hydroxyl groups and a side chain with hydroxyl, hydrogen, and an amine group.*
FDA Label Image

Label Pt 2 (Vial Label Pt 2)

Label Pt 2 (Vial Label Pt 2)
A clear glass vial containing a solution with a red cap. The label includes storage instructions to protect from light and not autoclave due to epinephrine content. Manufacturer indicated as Fresenius Kabi USA, LLC. The vial is for injection use, with warnings about color changes and precipitate in the solution.*
FDA Label Image

Label Pt 3 (Vial Label Pt 3)

Label Pt 3 (Vial Label Pt 3)
A clear glass vial with a red flip-off cap containing a clear solution. The vial label includes a barcode and partial lot and expiration information but the full proprietary name and strength are not visible on this side.*
FDA Label Image

Label Pt 1 (Vial Lbel Pt 1)

Label Pt 1 (Vial Lbel Pt 1)
Packaging label of Sensorcaine (Bupivacaine HCl and Epinephrine) Injection, USP, 0.25% strength, in a 50 mL multiple dose vial with red cap. The label includes a warning about sulfites and states the product is for infiltration and nerve block only. NDC 63323-461-57 is visible.*
FDA Label Image

Box Warning (Warning)

Box Warning (Warning)
This text panel provides warnings and precautions for SENSORCAINE (Bupivacaine HCl and Epinephrine) injection, solution. It details risks such as cardiac arrest, use restrictions in obstetrical anesthesia, local anesthetic toxicity management, contraindications with antimicrobial preservatives, and cautions for specific patient groups and drug interactions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.